ARKG vs BOTZ
ARK Genomic Revolution ETF vs Global X Robotics & Artificial Intelligence ETF
- • BOTZ has the lower expense ratio at 0.68% vs 0.75% for ARKG.
- • BOTZ pays a higher dividend yield (0.54%).
Side-by-side metrics
| Metric | ARKG | BOTZ |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.68% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.54% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $3.04B |
YTD return | 66.55% | -11.96% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 1.86 |
P/E ratio | — | 35.20 |
Last price | $47.17 | $32.39 |
Inception | — | — |
Issuer | ARK | Global X |
ARKG top holdings
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
BOTZ top holdings
| ISRG | Intuitive Surgical Inc | 9.94% |
| 6861.T | Keyence Corp | 8.65% |
| 6954.T | Fanuc Corp | 8.59% |
| NVDA | NVIDIA Corp | 7.81% |
| ABBN.SW | ABB Ltd | 7.71% |
| 6273.T | SMC Corp | 4.67% |
| 6383.T | Daifuku Co Ltd | 3.43% |
| 300124.SZ | Shenzhen Inovance Technology Co Ltd Class A | 2.93% |
| CGNX | Cognex Corp | 2.60% |
| TSLA | Tesla Inc | 2.40% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About BOTZ
BOTZ (Global X Robotics & Artificial Intelligence ETF) is Robotics, automation, and AI companies globally. Managed by Global X, the fund carries $3.0B in assets under management, an expense ratio of 0.68%, a dividend yield of 0.54%. Its largest holding is Intuitive Surgical Inc (ISRG), which represents 9.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.7%.